4//SEC Filing
Jungles Steven J 4
Accession 0000899243-20-020570
CIK 0001693011other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 6:15 PM ET
Size
7.7 KB
Accession
0000899243-20-020570
Insider Transaction Report
Form 4
Jungles Steven J
See Remarks
Transactions
- Conversion
Common Stock
2020-07-28+13,381→ 55,417 total(indirect: By Trust) - Conversion
Series A Convertible Preferred Stock
2020-07-28−100,000→ 0 total(indirect: By Trust)→ Common Stock (13,381 underlying)
Footnotes (1)
- [F1]On July 28, 2020, the Series A Convertible Preferred Stock automatically converted into Common Stock on a 7.4730-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001815595
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 6:15 PM ET
- Size
- 7.7 KB